bpc 157 ncbi BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Is BPC 157 Bad For

There is also a theoretical risk of 'QT prolongation' (a change in heart rhythm) when these types of drugs are used together

A unique aspect of this market is that goods are sold on the ground

Thus, we hypothesized that TBI can be attenuated by vitaminB 12 treatment through its beneficial role on axon regeneration after nerve injury

The ability of hydroxocobalamin to rapidly scavenge and detoxify cyanide by chelation has resulted in several acute animal and human studies using systemic hydroxocobalamin doses at suprapharmacological doses as high as 140 mg/kg to support its use as an intravenous (IV) treatment for cyanide exposure

doi: 10.1046/j.1445-5994.2003.00420.x